Return to Home

Masimo Corporation

MASI

Find Out if You Qualify for a Financial Reward by filling out the form below.

Lead Plaintiff Deadline:
October 23, 2023

Days Left:
-179

calendar

Masimo Corporation Form












Securities Fraud News does not share your information with others. There is no cost or obligation for you to submit.

Allegations

According to the complaint, defendants provided investors with material information concerning Masimo’s revenue and sales for the second quarter of fiscal 2023 and expected revenue for the full-year 2023. Defendants’ statements included, among other things, Masimo’s ability to deliver clinically proven new products to the healthcare markets thereby supporting defendants’ decision to forecast revenue of $550 million to $565 million for the quarter and increase its earnings-per-share estimates to between $3.59 per share and $3.69 per share. Defendants’ statements in this regard prompted an immediate and dramatic increase in the price of Masimo’s common stock. From a closing price of $167.31 per share on February 28, 2023 at the start of the Class Period, Masimo’s stock price climbed to $184.97 per share the following day on March 1, 2023 on unusually high volume. Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts. On July 17, 2023 Masimo issued a press release announcing its second quarter 2023 earnings. Defendants announced lower than expected revenue for the second quarter of fiscal 2023 and preliminarily decreased full-year revenue estimates for both healthcare and non-healthcare segments. On this news, the price of Masimo’s common stock declined dramatically. From a closing market price of $147.16 per share on July 17, 2023, Masimo’s stock price fell to $117.73 per share on July 18, 2023, a decline of nearly 20% in the span of just a single day.

Eligibility

In order to be included in the lawsuit, you must have incurred a loss on shares of Masimo purchased or acquired during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Masimo during the relevant time frame, you have until October 23, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Find More Cases

Ticker Symbol Company Name Join Deadline
INOD Innodata Inc. April 22, 2024 Join
DKS DICK's Sporting Goods, Inc. April 22, 2024 Join
FOXF Fox Factory Holding Corp. April 22, 2024 Join
LTRX Lantronix, Inc. April 23, 2024 Join
PANW Palo Alto Networks Inc. April 26, 2024 Join
KIND Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II April 29, 2024 Join
PLCE The Children's Place, Inc. April 29, 2024 Join
SNOW Snowflake Inc. April 29, 2024 Join
VTYX Ventyx Biosciences, Inc. April 30, 2024 Join
IRBT iRobot Corporation May 07, 2024 Join
AVXL Anavex Life Sciences Corporation May 13, 2024 Join
000 Next Bridge Hydrocarbons, Inc. May 14, 2024 Join
INVZ Innoviz Technologies Ltd. May 14, 2024 Join
SSRM SSR Mining Inc. May 17, 2024 Join
AGL agilon health, inc. May 20, 2024 Join
CC The Chemours Company May 20, 2024 Join
SHLS Shoals Technologies Group, Inc. May 21, 2024 Join
PLUG Plug Power Inc. May 21, 2024 Join
EVLV Evolv Technologies Holdings, Inc. May 24, 2024 Join
BLUE bluebird bio, Inc. May 28, 2024 Join
LUNA Luna Innovations Incorporated May 31, 2024 Join
HRT HireRight Holdings Corporation June 03, 2024 Join
VFS VinFast Auto Ltd. f/k/a Black Spade Acquisition Co. June 11, 2024 Join
QDEL QuidelOrtho Corporation f/k/a Quidel Corporation June 11, 2024 Join
PERI Perion Network Ltd. June 17, 2024 Join
ASTS AST SpaceMobile, Inc. June 17, 2024 Join